Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings — Stella

Recruiting

Back to Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice trials

Trial locations(1 site)

Germany

Novartis Investigative Site, Nuremberg

Key details

Sponsor

Novartis Pharmaceuticals

Enrollment target

~4,500 participants

Started

November 2025

Primary completion

March 2028

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov